Nippon India Pharma Fund
Direct · Growth: other plans of this fund
Same portfolio. Regular plans include a distributor’s fee.
· AMFI 118759
₹663.12
+16.2%over 1 year
Price of one unit (NAV) on 11 November 2026
NAV went from ₹570.57 on 11 November 2025 to ₹663.12 on 11 November 2026.
Past prices are not a forecast of anything.
Ask about this fund
Overview
- Kind of fund
- Sectoral
- Yearly fee
- 1.00%
- Since 30 September 2026
- Fund size
- ₹9,479 crore
- Started
- 1 January 2013
- Exit load
- 1% if sold within 1 month
- Compared against
- BSE Healthcare TRI
- Plan
- Direct · Growth
- Companies held
- 36
- 39 lines in all
- Holdings as at
- 30 August 2026
What does it hold?
Company size
- Large
- Mid
- Small
- Cash, bonds, abroad
- Nippon India Pharma Fund31%43%25%
Industries
- Healthcare98%
Top companies
10 of 36 companies · holdings as at 30 August 2026
- 112.4%
Sun Pharmaceutical Industries Ltd
LargeHealthcare
- 27.0%
Divi's Laboratories Ltd
LargeHealthcare
- 36.4%
Lupin Ltd
MidHealthcare
- 46.1%
Cipla Ltd
LargeHealthcare
- 55.2%
Apollo Hospitals Enterprise Ltd
LargeHealthcare
- 64.9%
Dr. Reddy's Laboratories Ltd
MidHealthcare
- 74.1%
Mankind Pharma Ltd.
MidHealthcare
- 83.9%
Sai Life Sciences Ltd.
SmallHealthcare
- 93.5%
Ajanta Pharma Ltd
MidHealthcare
- 103.3%
Glaxosmithkline Pharmaceuticals Ltd
MidHealthcare
Show all 36
- 112.9%
Max Healthcare Institute Ltd
MidHealthcare
- 122.8%
Ipca Laboratories Ltd
MidHealthcare
- 132.7%
Vijaya Diagnostic Centre Ltd
SmallHealthcare
- 142.5%
Medplus Health Services Ltd
SmallHealthcare
- 152.5%
Thyrocare Technologies Ltd
SmallHealthcare
- 162.4%
Gland Pharma Ltd
MidHealthcare
- 172.3%
Piramal Pharma Ltd
SmallHealthcare
- 182.1%
Abbott India Ltd
MidHealthcare
- 192.0%
Dr. Lal Pathlabs Ltd
SmallHealthcare
- 201.8%
Alkem Laboratories Ltd
MidHealthcare
- 211.7%
Narayana Hrudayalaya Ltd
MidHealthcare
- 221.6%
Aurobindo Pharma Ltd
MidHealthcare
- 231.6%
Pfizer Ltd
SmallHealthcare
- 241.5%
Syngene International Ltd
SmallHealthcare
- 251.4%
Suraksha Diagnostic Ltd.
SmallHealthcare
- 261.3%
Fortis Healthcare Ltd
MidHealthcare
- 271.3%
Emcure Pharmaceuticals Ltd.
MidHealthcare
- 281.2%
Anthem Biosciences Ltd.
MidHealthcare
- 291.1%
Akums Drugs And Pharmaceuticals Ltd.
SmallHealthcare
- 301.1%
Biocon Ltd
MidHealthcare
- 311.0%
Sanofi India Ltd
SmallHealthcare
- 320.9%
Sanofi Consumer Healthcare India Ltd
SmallHealthcare
- 330.5%
Indoco Remedies Ltd
SmallHealthcare
- 340.5%
Astrazeneca Pharma India Ltd
SmallHealthcare
- 350.4%
Molbio Diagnostics Ltd.
SmallHealthcare
- 360.2%
Concord Biotech Ltd.
SmallHealthcare
What does it cost?
1.00% a year: ₹100 on every ₹10,000 you hold.
The middle fee for Sectoral direct plans is 1.03%.
Exit load: 1% if sold within 1 month
How has it done?
- 1 year
- +16.2%
- 3 years, per year
- +18.7%
- 5 years, per year
- +15.4%
Worst fall so far: −24.0% (Oct 2015 to May 2017).
Against other Sectoral funds: out of 131 three-year stretches, it finished above the middle Sectoral fund in 65.
In Jan–Apr 2020 alone it fell 21.2%; the middle fund fell 40.5%.
Past prices are not a forecast of anything.
Events
- 30 September 2026Fee moved between 0.99% and 1.00% a year (5 changes, 10 Sep – 30 Sep 2026).
- 30 August 2026New portfolio published: holdings as at 30 August 2026.
- 20 August 2026Fee moved between 0.99% and 1.02% a year (8 changes, 1 Jul – 20 Aug 2026).
- 1 June 2026Fee changed from 0.93% to 1.02% a year.
- 27 May 2026Fee changed from 2.13% to 0.93% a year.
Show all 32
- 26 May 2026Fee changed from 1.45% to 2.13% a year.
- 25 May 2026Fee changed from 0.93% to 1.45% a year.
- 22 May 2026Fee changed from 0.94% to 0.93% a year.
- 21 May 2026Fee changed from 1.11% to 0.94% a year.
- 20 May 2026Fee changed from 0.93% to 1.11% a year.
- 19 May 2026Fee changed from 1.41% to 0.93% a year.
- 18 May 2026Fee changed from 0.93% to 1.41% a year.
- 7 May 2026Fee changed from 1.18% to 0.93% a year.
- 6 May 2026Fee changed from 0.94% to 1.18% a year.
- 1 May 2026Fee moved between 0.89% and 0.94% a year (6 changes, 26 Sep 2025 – 1 May 2026).
- 31 July 2025Fee moved between 0.88% and 0.93% a year (45 changes, 28 Mar 2024 – 31 Jul 2025).
- 27 March 2024Fee moved between 0.93% and 0.98% a year (4 changes, 10 Mar – 27 Mar 2024).
- 7 March 2024Fee moved between 0.95% and 0.99% a year (7 changes, 2 Feb – 7 Mar 2024).
- 29 January 2024Fee moved between 0.93% and 0.97% a year (10 changes, 20 Oct 2023 – 29 Jan 2024).
- 18 October 2023Fee moved between 0.96% and 1.01% a year (9 changes, 12 Sep – 18 Oct 2023).
- 3 August 2023Fee moved between 1.01% and 1.06% a year (13 changes, 19 Apr – 3 Aug 2023).
- 3 April 2023Fee changed from 1.26% to 1.06% a year.
- 28 February 2023Fee changed from 1.17% to 1.26% a year.
- 25 January 2023Fee changed from 1.16% to 1.17% a year.
- 16 January 2023Fee changed from 1.11% to 1.16% a year.
- 22 December 2022Fee changed from 1.05% to 1.11% a year.
- 19 October 2022Fee moved between 1.00% and 1.05% a year (2 changes, 29 Sep – 19 Oct 2022).
- 3 August 2022Fee changed from 1.06% to 1.00% a year.
- 8 July 2022Fee moved between 1.03% and 1.07% a year (3 changes, 5 May – 8 Jul 2022).
- 2 May 2022Fee changed from 0.88% to 1.03% a year.
- 27 March 2022Fee changed from 1.04% to 0.88% a year.
- 16 March 2022Fee moved between 1.03% and 1.04% a year (21 changes, 7 Jan – 16 Mar 2022).
Sources and dates
- Holdings
- Groww's page for this fund, month-end 30 August 2026
- Prices
- AMFI via mfapi.in, to 11 November 2026
- Fee
- Groww, from 30 September 2026
- Company sizes
- SEBI's rank by full market value, 25 September 2026